Az endocannabinoid rendszer szerepe és szabályozása a humán faggyúmirigyben  =  Role and regulation of the endocannabinoid system in the human sebaceous gland by Bíró, Tamás et al.
Tamás Bíró, OTKA NNF 78456 
1/9 
 
FINAL REPORT 
2010.01.01.  –  2011.03.31. 
 
ROLE AND REGULATION OF THE ENDOCANNABINOID SYSTEM IN THE 
HUMAN SEBACEOUS GLAND 
 
 
I. AIM OF THE PROJECT 
In the current, highly focused, basic research project performed by an expert, 
multidisciplinary, international research team, we have systematically and mechanistically 
investigated the role and regulation of the endocannabinoid system in the biology of the 
human sebaceous gland. 
 
 
II. BACKGROUND 
The sebaceous gland (SG) is one of the key adnexal components of the pilosebaceous unit of 
the human skin. Due recent research efforts, it has become evident that the SG is not only a 
mere “passive” cutaneous “adnexum” to establish the physico-chemical barrier function of the 
skin against constant environmental challenges (by producing the oil-enriched sebum), but it 
rather functions as an “active” neuro-immuno-endocrine cutaneous organ. Moreover, it 
was also proposed that the proper execution and regulation of the neuro-immuno-endocrine 
mechanisms in the SG take a central position in the establishment of the physiological human 
skin homeostasis. No wonder therefore that pathological alterations in sebaceous lipid 
synthesis and related immuno-endocrine functions very often lead to the development of such 
high-incidence clinical conditions as e.g. acne vulgaris, seborrhea, atopic eczema, etc. 
 
Intriguingly, various lipid mediators and signaling molecules of the emerging 
endocannabinoid system (ECS) have lately been identified in the skin. Indeed, several 
human skin cell compartments produce prototypic endocannabinoids such as anandamide (N-
arachidonoylethanolamine, AEA) and 2-arachidonoylglycerol (2-AG) as well as they express 
enzymes involved in the synthesis and metabolism of these lipid mediators. Moreover, G-
protein coupled metabotropic cannabinoid receptors (CB), i.e. CB1 and CB2, were identified 
both in situ and in vitro on numerous skin cell populations such as e.g. epidermal 
keratinocytes, keratinocyte subpopulations of hair follicles, and sebaceous gland-derived 
sebocytes.  
 
Recent studies have furthermore suggested that the cutaneous ECS is functional and 
implicated it in various biological processes. For example, by focusing on the human 
pilosebaceous unit, we have shown that the locally produced AEA, via the activation of CB1, 
inhibited in vitro hair shaft elongation and induced apoptosis-driven premature catagen 
regression [Telek et al, 2007]. Intriguingly – using human SG-derived immortalized, non-
malignant SZ95 sebocytes which establish one of the best available cell culture systems to 
model the biology of the human SG – we have furthermore presented that prototypic 
endocannabinoids are present in SZ95 sebocytes and, most probably via the stimulation of 
CB2-coupled intracellular signaling pathways, dose-dependently induce lipid production and 
(chiefly apoptosis-driven) cell death. In these cells, endocannabinoids also activated the 
mitogen-activated protein kinase (MAPK) system and up-regulated the expression of key 
genes involved in lipid synthesis (e.g. peroxisome proliferator-activated receptor, PPAR, 
isoforms and some of their target genes). Of further importance, we finally found that 
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sebocytes with “silenced” CB2 exhibited significantly suppressed basal lipid production 
[Dobrosi et al, 2008]. 
 
 
III. HYPOTHESIS 
Taken together, our previous results have suggested that human sebocytes utilize an 
autocrine/paracrine, endogenously (and most probably constitutively) active, CB2-mediated 
endocannabinoid signaling system for regulating lipid production and cell death. According 
to this, it was proposed that the constitutively active ECS in sebocytes may fundamentally be 
involved in the physiological regulation of human SG biology. Along these lines, it was 
furthermore hypothesized that possible alterations in the activity and/or regulation of the ECS 
may contribute to the pathogenesis of such SG-coupled skin disorders (e.g. acne vulgaris, 
seborrhea, dry skin, eczema) which are characterized by pathologically altered lipid synthesis 
and related immuno-endocrine functions. 
 
A validity of the above hypothesis was investigated during this project by defining the 
role ECS in the immuno-endocrine functions of the human SG as well as the regulation 
of the ECS by various sebaceous factors. 
 
 
IV. TASKS AND RESULTS 
Since we lack appropriate animal model systems compatible to the human SG, the majority of 
the below research efforts was carried out on in vitro cultured human SG-derived 
immortalized, non-malignant SZ95 sebocytes (Task 1). In addition, to translate the result 
obtained on in vitro cultured SZ95 sebocytes to the in vivo conditions, healthy and diseased 
human skin samples were also investigated (Task 2). In the below sections, we introduce the 
specific Tasks and present our experimental results obtained during the OTKA NNF project. 
 
Task 1.  To determine the expression, regulation, and functional roles of the ECS in the 
human SG – Experiments on in vitro cultured human SG-derived immortalized SZ95 
sebocytes 
Task 1.a. Functional expression of members of the ECS in human SZ95 sebocytes 
First, we investigated the molecular expression of elements of the ECS such as (i) receptors: 
metabotropic CB1 and CB2; ionotropic transient receptor potential vanilloid (TRPV) channels; 
and (ii) enzymes involved in the synthesis (NAPE-PLD, DAGL) or degradation (FAAH, 
MAGL) of the endocannabinoids. Using complementary static imaging techniques 
(immunocytochemistry methods followed by confocal microscopy, flow cytometry), Western 
blotting, and quantitative “real-time” Q-PCR, we have successfully identified these 
molecules in SZ95 sebocytes. Moreover, we have further confirmed that the sebaceous ECS 
is indeed functional since pharmacological inhibition as well as RNAi-mediated gene 
silencing of the enzymes profoundly altered the production of endocannabinoids (e.g. AEA, 
2-AG), as measured by mass spectrometry. 
 
To further assess the functional existence of the ECS in the SG, we have also started to 
investigate the effects of various phytocannabinoids, derived from the marijuana plant 
Cannabis sativa. Intriguingly, we found that Cannabidiol (CBD), a non-psychoactive 
phytocannabinoid – in contrast to the lipogenic effects of the endocannabinoids – did not 
affect basal lipid synthesis of the sebocytes. Of further importance, CBD markedly abrogated 
the effects of endocannabinoids as well as other lipogenic factors (e.g. arachidonic acid, 
testosterone, linoleic acid) to stimulate lipid synthesis. 
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We then investigated the involvement of various signaling mechanisms in the sebostatic 
action of CBD. Inhibition of CB1 or CB2 did not prevent the effect of CBD. However, the 
decrease of the extracellular Ca
2+
 concentration ([Ca
2+
]e) markedly suppressed the action of 
CBD to inhibit lipid synthesis. In numerous cellular systems, CBD was shown to modulate 
Ca
2+
-permeable TRP channels. Among these, we have identified the expression of TRPV1-V4 
and TRPA1 on SZ95 sebocytes. Indeed, CDB increased intracellular [Ca
2+
]i which was 
prevented by ruthenium red, a non-specific inhibitor of TRP channels. Of further importance, 
RNAi-mediated silencing of TRPV4 (but not of the other TRP channels) fully abrogated the 
action of CBD to suppress lipid synthesis. In addition, the specific TRPV4 agonist 
GSK1016790A fully mimicked the sebostatic action of CBD, again arguing for the 
involvement of TRPV4 in mediating the action of the phytocannabinoid (Fig. 1.). 
 
Fig. 1.  Effects of endocannabinoids 
and cannabidiol on lipid synthesis of 
human SZ95 sebocytes 
Endocannabinoids, via the 
stimulation of the CB2-MAPK-
PPAR isoforms pathway, stimulate 
sebaceous lipid synthesis. In 
contrast, cannabidiol (CBD) inhibits 
sebaceous lipogenesis (induced by 
various factors) by stimulating the 
ion channel TRPV4 and increasing 
[Ca
2+
]i. 
 
 
 
 
 
 
In a new collaborative effort, initiated with the Laboratory of Prof. Mauro Picardo (Cutaneous 
Physiopathology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy) a leading 
expert in the field of functional lipidomics, we have also started to investigate whether the 
sebostatic action of CBD to quantitatively suppress sebaceous lipid production is also realized 
in a “qualitative” manner; namely, we measured the effect of CBD on the level of individual 
lipids of the sebum produced by SZ965 sebocytes. Of great importance, we found that the 
“pro-acne agent” arachidonic acid, as expected, markedly elevated the levels of various free 
fatty acids (20:4, 22:4, 18:3), cholesterol ester, squalene, and certain acylglycerol derivatives, 
which effects were fully reversed by the application of CBD.  
 
We have also started to study the putative “down-stream” signaling mechanisms that may 
mediate the cellular effect of the TRPV4-mediated elevation of [Ca
2+
]i induced by CBD. We 
have tested antagonists of various Ca
2+
-dependent signal transduction mechanisms (e.g. 
protein kinase C isoforms, calcineurin/protein phosphatase 2B) but we were unable to 
modulate the cellular action of CBD. We have therefore launched a series of MicroArray 
study to reveal global gene expression changes induced by the phytocannabinoid; the analysis 
of these large amounts of data is under progress. 
 
Nevertheless, these above (quite intriguing) data introduce CBD as a molecule with a 
significant, “universal”, and both quantitative and qualitative sebostatic function and a novel 
mechanism of action (i.e. activation of TRPV4). Our findings may therefore encourage one to 
systematically explore whether CBD can be exploited in the management of such common 
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skin disorders (e.g. acne vulgaris, seborrhea) which are characterized by pathologically 
elevated lipid (sebum) production of the SGs. 
 
Task 1.b. Regulation of expression of elements of the ECS by endogenous mechanisms in 
human SZ95 sebocytes 
The aim of this Task was to reveal whether endogenous immuno-endocrine mechanisms, 
which were shown to play fundamental roles in SG biology, modulate the sebaceous ECS. 
In our studies, we investigated (i) components of the CRH-ACTH-cortisol axis and other 
POMC-derived peptides (α-MSH, β-endorphin); (ii) sexual steroids (estrogens, androgens); 
and (iii) pro- and anti-inflammatory mediators such as interleukins (e.g. IL-1β, IL-4, IL-6) 
and other cytokines (e.g. TNFα). 
 
Table 1. Effects of various hormones and mediators on the expressions of elements of the ECS in 
SZ95 sebocytes 
 
Treatment with 
Endocannabinoid 
(HPLC/MS) 
Quantitative “real-time” Q-PCR 
AEA 2-AG CB1 CB2 NAPE-
PLD 
FAAH 
CRH (a.v.)   NE no change  no change 
ACTH (a.v.)   NE no change no change no change 
Cortisol   NE    
α-MSH (a.v.)   NE no change no change no change 
β-endorphin (a.v.)   NE no change no change no change 
Testosterone (a.v.)   NE    
Estradiol   NE    
IL-1β   NE  no change no change 
IL-4 no change  NE no change no change no change 
IL-6 no change no change NE no change no change no change 
TNFα no change  NE no change no change no change 
Transforming growth 
factor-β2 
  NE no change no change no change 
Substance P (a.v.) no change no change NE no change no change no change 
Prolactin (a.v.)   NE no change no change no change 
 or : significant (p<0.05) up- or down-regulation. a.v.: these mediators were found to stimulate 
sebaceous lipid synthesis and/or were implicated in the pathogenesis of acne vulgaris. NE: not 
expressed 
 
Intriguingly, we found that most hormones (i.e. CRH, ACTH, α-MSH, β-endorphin, 
testosterone, prolactin), which were previously shown to stimulate sebaceous lipid synthesis 
and/or were implicated in the pathogenesis of acne [reviewed in Tóth et al., 2011]; as well as 
the pro-inflammatory IL-1β stimulated the production of the lipogenic endocannabinoids. 
In addition, some of them also up-regulated the expression of CB2 receptor which, as we have 
shown before [Dobrosi et al., 2008], mediates the lipid synthesis-promoting action of AEA 
and 2-AG. Conversely, the anti-lipogenic cortisol and estradiol suppressed 
endocannabinoid production and CB2 expression levels. Of further importance, those 
hormones which activate nuclear receptors (and hence modulate gene transcription) also 
modified the expressions of NAPE-PLD and FAAH. Finally, the other cytokines investigated 
and the neuropeptide substance P (which was also found to stimulate lipid synthesis) did not 
really affect the ECS. Collectively, these data (summarized in Table 1.) suggest that the 
sebaceous ECS in under the control of numerous immuno-endocrine mechanisms.  
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Task 1.c. Involvement of the ECS in cellular functions of endogenous immuno-endocrine 
mechanisms in human SZ95 sebocytes 
We have also investigated the putative involvement of the sebaceous ECS in the cellular 
effects of the above hormones and cytokines. For this, we first defined the exact effects of 
the above agents on various sebocyte functions such as lipid synthesis and cell death/survival. 
 
As expected, all of the above “lipogenic” hormones and mediators (i.e. CRH, ACTH, α-MSH, 
β-endorphin, testosterone, substance P, prolactin) stimulated the lipid synthesis of SZ95 
sebocytes (Nile Red-based fluorimetry). It should be noted, however, that their lipogenic 
effects were much less (cca. 20-40 %) than the degree of lipid synthesis induced by 
endocannabinoids (especially after short-term, 24-48 hrs treatment). Moreover, using a series 
of fluorimetric assays, we have also shown that most of these hormones decreased the 
viability of the cells, which effect is characterized by an induction of a chiefly apoptosis-
driven cell death. The other hormones and cytokines (listed in Table 1.) did not modulate 
cellular lipid synthesis and survival. 
 
To reveal whether the ECS may act as a “down-stream” target pathway of these lipogenic 
hormones, we also investigated how the activation or inhibition of ECS activity may affect 
their cellular functions. For this, we employed (i) pharmacological “inhibition” protocols (i.e. 
various antagonists); and (ii) molecular biology “inhibition” protocols (i.e. RNAi of CB2 
receptors and/or enzymes involved in the synthesis of endocannabinoids). The “ECS-
suppressed” cells were then challenged by the lipogenic hormones and the cellular responses 
were evaluated. 
 
Based on our functional experiments, the achieved results could be classified into 3 groups: 
 The lipogenic and apoptosis-inducing effects of testosterone and β-endorphin (which, 
as shown in Table 1., up-regulated endocannabinoid levels) were significantly, yet 
only partially (by cca. 40-50 %), prevented by AM630 (specific antagonist of CB2) or 
the RNAi-mediated silencing of CB2. These data suggest that the ECS plays a key 
role in mediating their actions. 
 In contrast, the cellular actions of CRH, ACTH, α-MSH, and prolactin, which also 
elevated endocannabinoid production (Table 1.), were intriguingly not modified by 
inhibition or down-regulation of CB2. These rather unexpected findings argue for that 
these agents induce cellular lipid synthesis independently from the ECS, most 
probably by acting via distinct signal transduction mechanisms. To test this 
hypothesis, we investigated the co-administration of these hormones with the 
endocannabinoids and with inhibitors of enzymes involved in endocannabinoid 
metabolism. We found that these “activation protocols” exerted additive lipogenic 
effects to the actions of these hormones suggesting that their effects to induce 
endocannabinoid synthesis was rather an “accidental” event.  
 Finally, the effects of substance P (which did not modify endocannabinoid levels) 
were also not affected by these interventions. 
 
Task 1.d. Regulation of immuno-endocrine functions of SZ95 sebocytes by the ECS 
We have also defined the possible regulation of the above hormones and cytokines and the 
related functions by the ECS (“the other way around” regulation). For this, first SZ95 
sebocytes were treated by AEA and 2-AG, harvested, and then subjected to (i) Human 
Cytokine Array (which allow the simultaneous detection of 36 cytokines typically involved in 
inflammatory processes, R&D systems); and (ii) Quantitative “real-time” Q-PCR analysis of 
the cytokines and enzymes involved in their synthesis. 
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We found that both endocannabinoid markedly elevated the expression (Q-PCR) and 
production (array) of the pro-inflammatory and “pro-acne” IL-1β, IL-4, IL-6, and IL-8. 
Interestingly, 2-AG (but not AEA) also stimulated the synthesis of the rather anti-
inflammatory IL-10. Of further importance, both endocannabinoids markedly induced the 
gene expressions of 5-lipoxygenase and cyclooxygenase-1 and -2, key enzymes involved in 
the production of such inflammatory mediators as leukotrienes and prostaglandins. In good 
accord with these findings, endocannabinoids elevated the production of key leukotrienes and 
prostaglandins (e.g. LTB4, PGE2). These data clearly suggest that endocannabinoids are 
indeed involved in the regulation of sebaceous inflammatory processes. 
 
 
Task 2. To define the expression patterns of elements of the ECS in the SG of human 
skin as well as their alterations in various human SG diseases 
In parallel to the above experiments performed on cultured human sebocytes, we have also 
investigated the in situ expression of elements of the ECS in the SG on healthy human skin 
samples as well as on tissues obtained from patients with various SG skin disorders. Along 
with healthy human skin samples, tissues of obtained from patients with SG diseases were 
also studied. 
 
Task 2.a. Sample collection 
We have selected numerous histological sections among samples of the histological bank of 
the Department of Dermatology and Pathology of the University. Moreover, we have 
collected numerous human skin samples (obtained mostly from dermatosurgery surplus 
material); these samples were either processed for routine histology (for 
immunohistochemical determinations) or total RNA was isolated (for quantitative “real-time” 
Q-PCR assessment). 
 
Task 2.b. Determination of expression patterns of elements of the ECS in the SG of healthy 
and diseased skin 
In parallel to sample collection, we have performed the identification of expression of ECS 
elements in the SG. We first employed immunohistochemistry on histological sections to 
identify the in situ protein expression of ECS members. We have successfully optimized the 
techniques (both for fluorescence and light microscopy visualization) for the detection of 
members of the ECS. Using immunohistochemistry, we found that all members of the ECS 
(i.e. CB receptors, enzymes) are expressed in human sebaceous glands in situ (Fig 2.), similar 
to those found in the cultured SZ95 sebocytes (see under Task 1.a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.  Immunohistochemical labeling of FAAH (A, alkaline phosphatase) and CB2 (B, FITC) 
in human SG in situ 
A B
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In addition, we have also established the methods of detecting specific mRNA transcripts of 
the ECS elements. For these experiments, whole SG samples were dissected from human skin 
samples and snap-frozen. Total RNA was then isolated and quantitative “real-time” Q-PCR 
experiments were performed using commercially available TaqMan probes. Using this 
technique, we have identified the specific mRNA transcripts of all members of the ECS, 
similar to the protein data detailed above. 
 
In addition, we compared the expression levels of ECS members in samples of healthy 
individuals and of patients suffering from acne vulgaris. Of great importance, our quantitative 
“real-time” Q-PCR data suggest that the expression of CB2 and NAPE-PLD (similar to the 
levels of 5-lipoxygenase, cyclooxygenase-2, and IL-6, used as “positive” controls for SGs in 
acne vulgaris skin) [Zouboulis et al., 2006] markedly increased in the diseased samples. In 
our ongoing experiments, we investigate the expression of the ECS members in rosacea and 
dry skin samples (atopic eczema). 
 
 
Additional experimental data 
Although it was not planned in the original Project, we also had the chance to investigate the 
role of the ECS in the regulation of human epidermal functions (i.e. proliferation, apoptosis, 
and intracellular Ca
2+
 homeostasis). Briefly, we found that, similar to human SG-derived 
sebocytes, the prototypic endocannabinoid AEA exhibited a profound role in the regulation of 
growth and survival of human epidermal keratinocytes. Of great importance, we have also 
shown that AEA initiated the onset of a novel signal transduction “chain-of-event” which 
involved the sequential activation of the metabotropic CB1 receptor  the ionotropic 
cannabinoid receptor TRPV1  and the influx of Ca2+. 
 
In addition, in close collaboration with our strategic collaboration partners (Laboratory of 
Prof. Paus), we are also involved in the exploration of the role of the ECS and related TRPV 
channels in the control of human hair growth. As part of these experiments, we have shown 
that the activation of the ionotropic cannabinoid receptor TRPV3 ion channel inhibited hair 
shaft elongation and induced premature catagen regression of the hair follicle. 
 
It appears, therefore, that on different human skin cell types, different ECS receptors 
and signaling pathways are involved in the regulation of key cutaneous functions. 
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